TAO WU to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications TAO WU has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.204
-
Associated factors for discontinuation of statin use one year after discharge in patients with acute coronary syndrome in China. BMJ Open. 2022 09 14; 12(9):e056236.
Score: 0.120
-
Six-month adherence to Statin use and subsequent risk of major adverse cardiovascular events (MACE) in patients discharged with acute coronary syndromes. Lipids Health Dis. 2017 Aug 15; 16(1):155.
Score: 0.084